Eton Pharmaceuticals Inc (NASDAQ: ETON) on Monday, plunged -7.91% from the previous trading day, before settling in for the closing price of $13.53. Within the past 52 weeks, ETON’s price has moved between $3.03 and $13.72.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 11165.96%. The company achieved an average annual earnings per share of -237.50%. With a float of $24.46 million, this company’s outstanding shares have now reached $25.84 million.
The extent of productivity of a business whose workforce counts for 30 workers is very important to gauge. In terms of profitability, gross margin is 59.3%, operating margin of -15.05%, and the pretax margin is -15.3%.
Eton Pharmaceuticals Inc (ETON) Insider Updates
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Eton Pharmaceuticals Inc is 5.31%, while institutional ownership is 37.14%. The most recent insider transaction that took place on Oct 23 ’24, was worth 79,814. In this transaction 10% Owner of this company bought 10,000 shares at a rate of $7.98, taking the stock ownership to the 2,770,000 shares. Before that another transaction happened on Oct 08 ’24, when Company’s 10% Owner bought 33,970 for $7.03, making the entire transaction worth $238,782. This insider now owns 2,760,000 shares in total.
Eton Pharmaceuticals Inc (ETON) Performance Highlights and Predictions
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.09 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.04) by -0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -237.50% per share during the next fiscal year.
Eton Pharmaceuticals Inc (NASDAQ: ETON) Trading Performance Indicators
Eton Pharmaceuticals Inc (ETON) is currently performing well based on its current performance indicators. A quick ratio of 1.41 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.28. Likewise, its price to free cash flow for the trailing twelve months is 152.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.21, a number that is poised to hit -0.01 in the next quarter and is forecasted to reach 0.42 in one year’s time.
Technical Analysis of Eton Pharmaceuticals Inc (ETON)
The latest stats from [Eton Pharmaceuticals Inc, ETON] show that its last 5-days average volume of 0.36 million was superior to 0.1 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 85.11%. Additionally, its Average True Range was 0.80.
During the past 100 days, Eton Pharmaceuticals Inc’s (ETON) raw stochastic average was set at 85.83%, which indicates a significant increase from 72.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 87.94% in the past 14 days, which was higher than the 56.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.66, while its 200-day Moving Average is $5.06. Now, the first resistance to watch is $13.62. This is followed by the second major resistance level at $14.77. The third major resistance level sits at $15.57. If the price goes on to break the first support level at $11.67, it is likely to go to the next support level at $10.87. Assuming the price breaks the second support level, the third support level stands at $9.72.
Eton Pharmaceuticals Inc (NASDAQ: ETON) Key Stats
Market capitalization of the company is 321.92 million based on 25,836K outstanding shares. Right now, sales total 31,640 K and income totals -940 K. The company made 10,320 K in profit during its latest quarter, and 630 K in sales during its previous quarter.
